Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7787]

ASCO GI: Ras status predicts response to second-line treatment with panitumumab for metastatic colorectal cancer

ASCO GI: Ras status predicts response to second-line treatment with panitumumab for metastatic colorectal cancer

ASCO GI: Pre-operative oral capecitabine chemotherapy is equivalent to infusional 5-FU for rectal cancer

ASCO GI: Pre-operative oral capecitabine chemotherapy is equivalent to infusional 5-FU for rectal cancer

ASCO GI: Adding the targeted therapy ramucirumab to standard second-line chemotherapy improves survival, quality of life for patients with metastatic gastric cancer

ASCO GI: Adding the targeted therapy ramucirumab to standard second-line chemotherapy improves survival, quality...

FDA approval for combination of trametinib with dabrafenib for treatment of melanoma

FDA approval for combination of trametinib with dabrafenib for treatment of melanoma

New type of immunotherapy shows potential in advanced lung cancer

New type of immunotherapy shows potential in advanced lung cancer

Metastatic cancer cells implode on protein contact

Metastatic cancer cells implode on protein contact

Paclitaxel plus gemcitabine recieves European marketing authorisation for first-line treatment of patients with metastatic pancreatic cancer

Paclitaxel plus gemcitabine recieves European marketing authorisation for first-line treatment of patients with...

European Commission approves update of cetuximab metastatic colorectal cancer labeling to patients with RAS wild-type tumours

European Commission approves update of cetuximab metastatic colorectal cancer labeling to patients with RAS wild...

Recurrent ovarian cancers respond to cancer vaccine after “reprogramming” with decitabine

Recurrent ovarian cancers respond to cancer vaccine after “reprogramming” with decitabine

SABCS 2013: Changing chemotherapy not beneficial for metastatic breast cancer patients With elevated circulating tumour cells

SABCS 2013: Changing chemotherapy not beneficial for metastatic breast cancer patients With elevated circulating...

More from ecancer